Share-based Compensation - Stock Transactions (Details) (Predecessor, USD $) In Thousands, except Share data, unless otherwise specified	5 Months Ended	12 Months Ended
	Jun. 06, 2012	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Beginning balance, Outstanding, Shares	270,753	270,753
Granted, shares	90,520
Ending balance, Outstanding, Shares	361,273
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Beginning balance, Outstanding, Weighted average exercise price (in dollars per share)	$ 34.16	$ 34.16
Granted, Weighted average exercise price (in dollars per share)	$ 28.42
Ending balance, Outstanding, Weighted average exercise price (in dollars per share)	$ 32.71
Outstanding, Weighted average remaining contractual term (in years)		7 years 4 months 17 days
Outstanding, Aggregate intrinsic value	$ 280		$ 182
TRSUs
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Beginning balance, Outstanding, (in shares)	28,748	28,748
Dividends accrued (in shares)	110
Granted (in shares)	0
Vested (in shares)	(24,829)
Vested (accelerated) (in shares)	(4,029)
Forfeited or expired (in shares)	0
Ending balance, Outstanding, (in shares)	0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Beginning balance, Outstanding, Weighted average grant-date fair value (in dollars per share)	$ 36.75	$ 36.75
Dividends accrued, Weighted average grant-date fair value (in dollars per share)	$ 0.00
Granted, Weighted average grant-date fair value (in dollars per share)	$ 0.00
Vested, Weighted average grant-date fair value (in dollars per share)	$ 36.48
Vested (acclerated), Weighted average grant-date fair value (in dollars per share)	$ 38.55
Forfeited or expired, Weighted average grant-date fair value (in dollars per share)	$ 0.00
Ending balance, Outstanding, Weighted average grant-date fair value (in dollars per share)	$ 0.00
PRSUs
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Beginning balance, Outstanding, (in shares)	148,949	148,949
Dividends accrued (in shares)	1,138
Granted (in shares)	67,740
Vested (in shares)	(41,016)
Vested (accelerated) (in shares)	(63,834)
Forfeited or expired (in shares)	(112,977)
Ending balance, Outstanding, (in shares)	0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Beginning balance, Outstanding, Weighted average grant-date fair value (in dollars per share)	$ 31.77	$ 31.77
Dividends accrued, Weighted average grant-date fair value (in dollars per share)	$ 0.00
Granted, Weighted average grant-date fair value (in dollars per share)	$ 28.42
Vested, Weighted average grant-date fair value (in dollars per share)	$ 23.46
Vested (acclerated), Weighted average grant-date fair value (in dollars per share)	$ 35.37
Forfeited or expired, Weighted average grant-date fair value (in dollars per share)	$ 31.13
Ending balance, Outstanding, Weighted average grant-date fair value (in dollars per share)	$ 0.00

Truven Holding Corp. 10-K